Can a new pill slow Alzheimer's? major trial launches
Disease control
Not yet recruiting
This study tests whether MLC901 (NeuroAiD™II) can improve thinking and memory in people with mild to moderate Alzheimer's disease. About 350 adults aged 50 and older will receive either the study drug or a placebo for several months. Researchers will measure changes in cognitive …
Phase: PHASE3 • Sponsor: Moleac Pte Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC